You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020113013
Dec 20203407
Jan 20214308
Feb 20211401
Mar 20213807
Apr 20214004
May 2021507
Jun 2021003
Jul 2021007
Aug 2021008
Sep 2021004
Oct 202118020
Nov 202118021
Dec 20211604
Jan 20221401
Feb 20222002
Mar 20221204
Apr 20223201
May 20221401
Jun 20221801
Jul 20221200
Aug 20222003
Sep 20221201
Oct 2022801
Nov 20223802
Dec 20222203
Jan 20231202
Feb 20231600
Mar 20231001
Apr 20231200
May 2023600
Jun 2023801
Jul 20231206
Aug 20231203
Sep 20231000
Oct 20232602
Nov 20231603
Dec 20234401
Jan 20242601
Feb 20242400
Mar 20242202
Apr 20241800
May 20242401
Jun 20243202
Jul 20242202
Aug 20241601
Sep 20241201
Oct 20241401
Nov 2024800
Dec 20242603
Jan 20251807
Feb 2025200
Apr 2025003
May 2025003
Jun 2025003
Total10090183